Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization.
about
Epidemiology, classification, and modifiable risk factors of peripheral arterial diseaseDevelopment of administrative data algorithms to identify patients with critical limb ischemia.The effects of intermittent negative pressure on the lower extremities' peripheral circulation and wound healing in four patients with lower limb ischemia and hard-to-heal leg ulcers: a case report.Maggot debridement therapy for a patient with critical limb ischaemia and severe cardiac dysfunction: possibility of limb salvage.Always contact a vascular interventional specialist before amputating a patient with critical limb ischemiaMyD88 and TRIF mediate divergent inflammatory and regenerative responses to skeletal muscle ischemia.Outcomes of Critical Limb Ischemia in an Urban, Safety Net Hospital Population with High WIfI Amputation Scores.Is atherectomy the best first-line therapy for limb salvage in patients with critical limb ischemia?Optimal management of infrainguinal arterial occlusive diseasePeripheral arterial disease: a literature review.TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathwaysHMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.Post-treatment neutrophil-lymphocyte ratio independently predicts amputation in critical limb ischemia without operation.Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not.Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model.Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System.High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury.The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration.Risk assessment in the patient with established peripheral arterial disease.TIE2-expressing monocytes/macrophages regulate revascularization of the ischemic limbCritical limb ischemia: medical and surgical management.Therapeutic Effects of Successful Angioplasty on the Aorta and Lower Limb Arteries on the Healing of Chronic Ischemic WoundsA phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease.Wound Closure in Smoking Peripheral Arterial Disease Patients With Treatment-Refractory Ulcerations: A 12-Month Follow-up Case Series.Domains that Determine Quality of Life in Vascular Amputees.A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease.Diagnostics and treatment of the diabetic foot.The path from art to evidence in treating critical limb ischaemia--reflections on 35 years' experience.Critical and acute limb ischemia: an overview.Hyperbaric oxygen for the treatment of nonhealing arterial insufficiency ulcers.What can I do with a patient with diabetes and critically impaired limb perfusion who cannot be revascularized?A review of the surgical management of heel pressure ulcers in the 21st century.Limb ischemia: cardiovascular diagnosis and management from head to toe.Preventing and treating foot complications associated with diabetes mellitus.Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication.Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.Management of Patients With Venous Leg Ulcers: Challenges and Current Best Practice.Conservative Treatment in Selected Patients with Severe Critical Limb Ischemia.Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.
P2860
Q24681271-4E4C4F1B-CF06-4269-8C84-817AF55B2B95Q30872920-27685DC1-EB1F-456C-AEBF-4A58C4A99113Q33469134-976DC624-EF9E-4123-8A2A-91B4D57FD2C8Q33712173-DA327AF3-21FB-4FCD-931F-77F1368DD55EQ33843965-DFCC46C4-3DA7-4781-81CB-5CFD11FFB7C6Q33902855-AA8A5DCF-0E33-4198-9C58-79FE22CFEE58Q33923438-43575806-CBA7-44C0-A48D-5D7BAA0D5CC8Q33962534-BD5BE0EE-CD60-4628-A459-1701B64A19B8Q34434785-37C97907-FAF1-44A5-A2BD-846FE475BFEDQ34451668-1FDD2C4A-8DD2-48E8-807D-5426B85DA194Q34500561-89254700-71BC-494C-8C7F-9ECC8A8B0EB2Q34588764-2DFF884D-0F28-42F3-998B-A92F28460F2AQ35007558-FC09B95E-DAB3-4D67-A6D3-BB10222F9FCDQ35565212-8FF13E37-2F0E-48DD-A13D-25CD4D352FD8Q35685017-C3B7F286-4C01-467B-9B8E-5505CD6BA178Q35996757-4B954374-A81A-4562-A2E1-9D87D411D576Q36279463-7EAED7D5-D227-43DA-8BC9-AC4C6977AC7DQ36706670-70630275-BB47-46BD-AAE2-F0D31CE0CDC9Q36835877-EFA76837-DE8B-4343-94B4-26477D180960Q37019601-84A97AB5-FEAD-4549-8CBE-5DB6DEC6C81DQ37188563-C753ADF8-E654-4708-AD34-A22DB2F66D52Q37238150-22F234DB-604F-4B34-A77A-29BA3606F6CCQ37263463-6938DE56-376D-406E-B030-DFBD9A0BB050Q37344037-4BE4C5AF-3C85-4125-9357-B2CC34194362Q37551554-51B09770-913A-4B73-BDD2-C39E1CB53C07Q37625112-50E1F213-2E5D-4513-90B0-3FA262303256Q37978288-7BA86D05-D13C-4FD6-BE13-C5BA8E822C16Q37988404-B8D5DB68-EACE-42A3-87C1-FAC59E538F2AQ38012696-655DD309-AE7D-4BB7-873C-2CE6E8154152Q38070672-CB91FC4C-27EF-49A2-AA89-A8DC7B050D37Q38213107-76EDDE8D-2C01-4515-B4F7-094FAE68AB1AQ38261175-BF66F1FC-C384-4CDF-9591-1019F404717DQ38356304-67A84CE2-30BE-443D-B729-A42522CC5F32Q38511050-7C19F7FA-1982-4A20-8D90-52C32CCD4C0DQ38568843-BD193B34-ABBC-4627-8DE5-40B8C4B08517Q39500446-4F234238-D824-4ECB-9897-1778CE35B2FCQ40356750-18BFD53A-DC44-4170-8635-A90F52176233Q40705570-ABA6534D-04D6-4538-9667-D77E2B6958E9Q41039218-468B94BD-94AA-449D-9E9F-E0FECB124CE3Q41090665-07F20E9B-69A3-4BED-8C13-786FA1294DE2
P2860
Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Natural history of limbs with ...... ted without revascularization.
@en
Natural history of limbs with ...... ted without revascularization.
@nl
type
label
Natural history of limbs with ...... ted without revascularization.
@en
Natural history of limbs with ...... ted without revascularization.
@nl
prefLabel
Natural history of limbs with ...... ted without revascularization.
@en
Natural history of limbs with ...... ted without revascularization.
@nl
P2093
P1476
Natural history of limbs with ...... ted without revascularization.
@en
P2093
Blair A Keagy
Brian Armstrong
Joseph J Fulton
Mark A Farber
Robert C Mendes
Stephen W Davies
William A Marston
P304
P356
10.1016/J.JVS.2006.03.026
P577
2006-07-01T00:00:00Z